Literature DB >> 23953169

Differences in the acceptability of non-abstinence goals by type of drug among American substance abuse clinicians.

Harold Rosenberg1, Alan K Davis.   

Abstract

To assess whether acceptability of non-abstinence outcome goals varied depending on the specific drug a client consumes (alcohol, cannabis, amphetamine, heroin, cocaine, MDMA/ecstasy, polydrug), severity of diagnosis (DSM-IV Abuse vs. Dependence), and finality of outcome goal (intermediate vs. final), we recruited 432 clinicians to complete a web-based questionnaire. More respondents rated non-abstinence acceptable as an intermediate goal for clients diagnosed with alcohol abuse (44%) or cannabis abuse (43%) than for clients diagnosed as abusing the other listed drugs (23 to 31%). Similarly, larger proportions of respondents rated non-abstinence as acceptable as a final goal for clients diagnosed with alcohol abuse (30%) or cannabis abuse (24%) than for clients diagnosed as abusing the other drugs (11 to 13%). Only 9 to 13% of respondents rated non-abstinence as an acceptable final goal for clients diagnosed with dependence, but 20% to 30% rated non-abstinence as acceptable as an intermediate goal for clients diagnosed as dependent.
© 2013.

Entities:  

Keywords:  Controlled drinking; Controlled drug use; Harm reduction; Non-abstinence

Mesh:

Year:  2013        PMID: 23953169     DOI: 10.1016/j.jsat.2013.07.005

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  12 in total

1.  Using contingency management procedures to reduce at-risk drinking in heavy drinkers.

Authors:  Donald M Dougherty; Sarah L Lake; Nathalie Hill-Kapturczak; Yuanyuan Liang; Tara E Karns; Jillian Mullen; John D Roache
Journal:  Alcohol Clin Exp Res       Date:  2015-04       Impact factor: 3.455

2.  Use of continuous transdermal alcohol monitoring during a contingency management procedure to reduce excessive alcohol use.

Authors:  Donald M Dougherty; Nathalie Hill-Kapturczak; Yuanyuan Liang; Tara E Karns; Sharon E Cates; Sarah L Lake; Jillian Mullen; John D Roache
Journal:  Drug Alcohol Depend       Date:  2014-07-11       Impact factor: 4.492

3.  Development and Validation of the Therapist Barriers to Engaging Parents (TBEP) Measure.

Authors:  Morgan E Dynes; Carolyn J Tompsett; Sarah E Domoff
Journal:  Community Ment Health J       Date:  2018-08-14

4.  Transdermal alcohol concentration data collected during a contingency management program to reduce at-risk drinking.

Authors:  Donald M Dougherty; Tara E Karns; Jillian Mullen; Yuanyuan Liang; Sarah L Lake; John D Roache; Nathalie Hill-Kapturczak
Journal:  Drug Alcohol Depend       Date:  2014-12-31       Impact factor: 4.492

5.  Patterns of Non-injection Drug Use Associated with Injection Cessation among Street-Involved Youth in Vancouver, Canada.

Authors:  Stephanie Lake; Thomas Kerr; Ekaterina Nosova; M-J Milloy; Evan Wood; Kora DeBeck
Journal:  J Urban Health       Date:  2018-04       Impact factor: 3.671

6.  Recovery Goals and Long-term Treatment Preference in Persons Who Engage in Nonmedical Opioid Use.

Authors:  Kaitlyn R Hay; Andrew S Huhn; David Andrew Tompkins; Kelly E Dunn
Journal:  J Addict Med       Date:  2019 Jul/Aug       Impact factor: 3.702

7.  Group Therapy for Substance Use Disorders: A Survey of Clinician Practices.

Authors:  Dennis C Wendt; Joseph P Gone
Journal:  J Groups Addict Recover       Date:  2017-12-08

8.  Recovery definitions: Do they change?

Authors:  Lee Ann Kaskutas; Jane Witbrodt; Christine E Grella
Journal:  Drug Alcohol Depend       Date:  2015-06-24       Impact factor: 4.492

9.  Acceptability of nonabstinent treatment outcome goals among addiction treatment providers in Ukraine.

Authors:  Alan K Davis; Tetiana Nickelsen; Robert A Zucker; Erin E Bonar; Maureen A Walton
Journal:  Psychol Addict Behav       Date:  2018-04-12

10.  American counselors' acceptance of non-abstinence outcome goals for clients diagnosed with co-occurring substance use and other psychiatric disorders.

Authors:  Alan K Davis; Harold Rosenberg; Joseph A Rosansky
Journal:  J Subst Abuse Treat       Date:  2017-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.